CD226 and hepatocellular carcinoma: Serum levels of sCD155 were significantly higher in patients with HCC compared with both HDs and no HCC subjects (Figure 1a) and this was accompanied by a simultaneously lower expression of DNAM-1 in NK cells from HCC patients (Figure 1b).